Navin Fluorine International Issues Notice for Transfer of Unclaimed Shares to IEPF
Navin Fluorine International Limited has issued a regulatory notice regarding mandatory transfer of equity shares to IEPF for shareholders with unclaimed dividends spanning seven consecutive years. The transfer deadline is July 25, 2026, with shareholders required to claim unpaid dividends from Final Dividend 2018-19 onwards by July 15, 2026. The company has provided comprehensive support through individual communications, website details, and registrar contact information to assist affected shareholders in preventing share transfer.

*this image is generated using AI for illustrative purposes only.
Navin Fluorine International Limited has issued a mandatory regulatory notice to shareholders regarding the impending transfer of equity shares to the Investor Education & Protection Fund (IEPF). The notice, published in newspapers on April 2, 2026, addresses shareholders whose dividend payments have remained unclaimed for extended periods.
Regulatory Compliance and Transfer Requirements
Pursuant to Section 124 of the Companies Act, 2013 read with the IEPF (Accounting, Audit, Transfer and Refund) Rules, 2016, the company is legally required to transfer shares to the IEPF Authority where dividends have remained unclaimed or unpaid for seven consecutive years or more. The company has already sent individual communications to shareholders whose shares have become due for this mandatory transfer.
Critical Timeline for Shareholders
| Parameter: | Details |
|---|---|
| Transfer Due Date: | July 25, 2026 |
| Final Claim Deadline: | July 15, 2026 |
| Affected Dividends: | Final Dividend 2018-19 onwards |
| Notice Publication: | April 2, 2026 |
Shareholders must claim or encash their unpaid dividends from Final Dividend 2018-19 onwards by July 15, 2026 to prevent the transfer of their shares to IEPF. If dividends remain unclaimed by the due date, the company will proceed with the mandatory transfer process.
Shareholder Information and Support
The company has made detailed information available to affected shareholders through multiple channels:
- Website Access: Complete details of shareholders due for transfer are available at https://nfil.in/investor/unpaid.html
- Individual Communications: Personal notices have been sent to all affected shareholders
- Newspaper Publication: Public notices published in Financial Express and regional language newspapers
Post-Transfer Recovery Process
Even after shares and dividends are transferred to IEPF, shareholders retain the right to reclaim them. The recovery process involves:
- Filing Web Form IEPF-5 with the IEPF Authority
- Following applicable rules and procedures
- Accessing the form through the official IEPF website at www.iepf.gov.in
Contact Information for Queries
For any queries regarding this matter, shareholders can contact the company's Registrar and Share Transfer Agent:
| Contact Details: | Information |
|---|---|
| Agent: | KFin Technologies Limited |
| Unit: | Navin Fluorine International Limited |
| Address: | Selenium, Tower B, Plot No. 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad-500032 |
| Phone: | +91 40 67162222 |
| Toll Free: | 1800-309-4001 |
| Email: | einward.ris@kfintech.com |
The notice was signed by Niraj B. Mankad, President Legal and Company Secretary, and filed with both BSE Limited (Stock Code: 532504) and National Stock Exchange of India Limited (Stock Code: NAVINFLUOR EQ) in compliance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Navin Fluorine International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.75% | +4.92% | -3.23% | +34.76% | +55.32% | +101.37% |
How might the transfer of unclaimed shares to IEPF affect Navin Fluorine's shareholding pattern and voting dynamics in upcoming corporate decisions?
What impact could this mandatory share transfer have on Navin Fluorine's stock liquidity and market capitalization in the near term?
Will other chemical and pharmaceutical companies face similar large-scale IEPF transfers, potentially creating sector-wide shareholding restructuring?


































